Edition:
United States

D Pharm Ltd (DPRM.TA)

DPRM.TA on Tel Aviv Stock Exchange

80.00ILa
23 May 2017
Change (% chg)

1.60 (+2.04%)
Prev Close
78.40
Open
80.00
Day's High
80.00
Day's Low
78.40
Volume
10
Avg. Vol
3,238
52-wk High
225.00
52-wk Low
60.00

Latest Key Developments (Source: Significant Developments)

D Pharm Ltd receives final positive results from a pilot Phase 2 study
Thursday, 30 Jul 2015 08:00am EDT 

D Pharm Ltd:Receives final positive results from a pilot Phase 2 study.Clinical study exploring DP-b99 in patients with acute high-risk inflammation of the pancreas.Preclinical and clinical data indicate a favorable safety profile for DP-b99.  Full Article

More From Around the Web

No consensus analysis data available.